SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ballyshannon Partners LP

(Last) (First) (Middle)
1150 FIRST AVENUE
SUITE 600

(Street)
KING OF PRUSSIA PA 19406

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
nFinanSe Inc. [ NFSE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/16/2010
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/16/2010 M(1) 225,000 A $0.01 704,937 D
Common Stock 03/16/2010 F(1) 22,500 D $0.1 682,437 D
Common Stock 03/16/2010 M(2) 112,500 A $0.01 794,937 D
Common Stock 03/16/2010 F(2) 11,250 D $0.1 783,687 D
Common Stock 03/16/2010 M(3) 32,500 A $0.01 816,187 D
Common Stock 03/16/2010 F(3) 3,250 D $0.1 812,937 D
Common Stock 03/16/2010 M(4) 25,000 A $0.01 837,937 D
Common Stock 03/16/2010 F(4) 2,500 D $0.1 835,437 D
Common Stock 03/16/2010 M(5) 25,000 A $0.01 860,437 D
Common Stock 03/16/2010 F(5) 2,500 D $0.1 857,937 D
Common Stock 03/16/2010 M(6) 100,000 A $0.01 957,937 D
Common Stock 03/16/2010 F(6) 10,000 D $0.1 947,937 D
Common Stock 03/16/2010 M(7) 100,000 A $0.01 1,047,937 D
Common Stock 03/16/2010 F(7) 10,000 D $0.1 1,037,937 D
Common Stock 03/16/2010 M(8) 50,000 A $0.01 1,087,937 D
Common Stock 03/16/2010 F(8) 5,000 D $0.1 1,082,937 D
Common Stock 03/16/2010 M(9) 43,000 A $0.01 1,125,937 D
Common Stock 03/16/2010 F(9) 4,300 D $0.1 1,121,637 D
Common Stock 03/16/2010 M(10) 2,117,000 A $0.01 3,238,637 D
Common Stock 03/16/2010 F(10) 211,700 D $0.1 3,026,937 D
Common Stock 03/16/2010 M(11) 6,071,770 A $0.01 9,098,707 D
Common Stock 03/16/2010 F(11) 607,177 D $0.1 8,491,530 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant to Purchase Common Stock $0.01 03/16/2010 M(1) 225,000 06/29/2007 06/29/2012 Common Stock 225,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(2) 112,500 06/13/2008 06/13/2013 Common Stock 112,500 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(3) 32,500 07/21/2008 07/21/2013 Common Stock 32,500 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(4) 25,000 11/26/2008 11/26/2010 Common Stock 25,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(5) 25,000 12/30/2008 12/30/2010 Common Stock 25,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(6) 100,000 01/23/2009 01/23/2011 Common Stock 100,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(7) 100,000 05/07/2009 05/07/2014 Common Stock 100,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(8) 50,000 06/04/2009 06/04/2014 Common Stock 50,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(9) 43,000 06/11/2009 06/11/2014 Common Stock 43,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(10) 2,117,000 06/11/2009 06/11/2014 Common Stock 2,117,000 $0 0 D
Warrant to Purchase Common Stock $0.01 03/16/2010 M(11) 6,071,770 02/23/2010(12) 08/21/2014 Common Stock 6,071,770 $0 0 D
Explanation of Responses:
1. On March 16, 2010, Ballyshannon Partners, L.P. (?Ballyshannon?) exercised a warrant to purchase 225,000 shares of common stock (?Common Stock?). Ballyshannon exercised the warrant on a net basis which resulted in nFinanSe Inc. (the ?Company?) retaining 22,500 shares of Common Stock for the warrant exercise price and the Company issued 202,500 shares of Common Stock to Ballyshannon.
2. On March 16, 2010, Ballyshannon exercised a warrant to purchase 112,500 shares of Common Stock. Ballyshannon used the net exercise feature of the warrant which resulted in the Company retaining 11,250 shares of Common Stock for the warrant exercise price and the Company issued 101,250 shares of Common Stock to Ballyshannon.
3. On March 16, 2010, Ballyshannon exercised a warrant to purchase 32,500 shares of Common Stock. Ballyshannon used the net exercise feature of the warrant which resulted in the Company retaining 3,250 shares of Common Stock for the warrant exercise price and the Company issued 29,250 shares of Common Stock to Ballyshannon.
4. On March 16, 2010, Ballyshannon exercised a warrant to purchase 25,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 2,500 shares of Common Stock for the warrant exercise price and the Company issued 22,500 shares of Common Stock to Ballyshannon.
5. On March 16, 2010, Ballyshannon exercised a warrant to purchase 25,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 2,500 shares of Common stock for the warrant exercise price and the Company issued 22,500 shares of Common Stock to Ballyshannon.
6. On March 16, 2010, Ballyshannon exercised a warrant to purchase 100,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 10,000 shares of Common Stock for the warrant exercise price and the Company issued 90,000 shares of Common Stock to Ballyshannon.
7. On March 16, 2010, Ballyshannon exercised a warrant to purchase 100,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 10,000 shares of Common Stock for the warrant exercise price and the Company issued 90,000 shares of Common Stock to Ballyshannon.
8. On March 16, 2010, Ballyshannon exercised a warrant to purchase 50,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 5,000 shares of Common Stock for the warrant exercise price and the Company issued 45,000 shares of Common Stock to Ballyshannon.
9. On March 16, 2010, Ballyshannon exercised a warrant to purchase 43,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 4,300 shares of Common Stock for the warrant exercise price and the Company issued 38,700 shares of Common Stock to Ballyshannon.
10. On March 16, 2010, Ballyshannon exercised a warrant to purchase 2,117,000 shares of Common Stock. Ballyshannon exercised the warrant on a net basis which resulted in the Company retaining 211,700 shares of Common Stock for the warrant exercise price and the Company issued 1,905,300 shares of Common Stock to Ballyshannon.
11. On March 16, 2010, Ballyshannon exercised a warrant to purchase 6,071,770 shares of Common Stock. Ballyshannon used the net exercise feature of the warrant which resulted in the Company retaining 607,177 shares of Common Stock for the warrant exercise price and the Company issued 5,464,593 shares of Common Stock to Ballyshannon.
12. This warrant was originally issued on August 21, 2009 and became exercisable on February 23, 2010 pursuant to the warrant amendment by and between the Company and Ballyshannon dated as of February 23, 2010 as discussed in the Company?s Current Report on Form 8-K filed with the Securities and Exchange Commission (the ?SEC?) on March 1, 2010 and in the Schedule 13D as filed by the Reporting Person with the SEC on March 3, 2010.
Remarks:
/s/ Bruce E. Terker, President of Ballyshannon Partners, Inc., General Partner of Ballyshannon Partners, L.P. 03/17/2010
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.